Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Glucose-regulated protein 58 modulates β-catenin protein stability in a cervical adenocarcinoma cell line

Authors: Chia-Jung Liao, Tzu-I Wu, Ya-Hui Huang, Ting-Chang Chang, Chyong-Huey Lai, Shih-Ming Jung, Chuen Hsueh, Kwang-Huei Lin

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Cervical cancer continues to threaten women’s health worldwide, and the incidence of cervical adenocarcinoma (AD) is rising in the developed countries. Previously, we showed that glucose-regulated protein 58 (Grp58) served as an independent factor predictive of poor prognosis of patients with cervical AD. However, the molecular mechanism underlying the involvement of Grp58 in cervical carcinogenesis is currently unknown.

Methods

DNA microarray and enrichment analysis were used to identify the pathways disrupted by knockdown of Grp58 expression.

Results

Among the pathway identified, the WNT signaling pathway was one of those that were significantly associated with knockdown of Grp58 expression in HeLa cells. Our experiments showed that β-catenin, a critical effector of WNT signaling, was stabilized thereby accumulated in stable Grp58 knockdown cells. Membrane localization of β-catenin was observed in Grp58 knockdown, but not control cells. Using a transwell assay, we found that accumulated β-catenin induced by Grp58 knockdown or lithium chloride treatment inhibited the migration ability of HeLa cells. Furthermore, an inverse expression pattern of Grp58 and β-catenin was observed in cervical tissues.

Conclusions

Our results demonstrate that β-catenin stability is negatively regulated by Grp58 in HeLa cells. Overexpression of Grp58 may be responsible for the loss of or decrease in membranous β-catenin expression in cervical AD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011, 22 (12): 2675-2686. 10.1093/annonc/mdr015.CrossRefPubMed Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J: Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011, 22 (12): 2675-2686. 10.1093/annonc/mdr015.CrossRefPubMed
2.
go back to reference Gien LT, Beauchemin MC, Thomas G: Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010, 116 (1): 140-146. 10.1016/j.ygyno.2009.09.040.CrossRefPubMed Gien LT, Beauchemin MC, Thomas G: Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010, 116 (1): 140-146. 10.1016/j.ygyno.2009.09.040.CrossRefPubMed
3.
go back to reference Hildesheim A, Berrington de Gonzalez A: Etiology and prevention of cervical adenocarcinomas. J Natl Cancer Inst. 2006, 98 (5): 292-293. 10.1093/jnci/djj098.CrossRefPubMed Hildesheim A, Berrington de Gonzalez A: Etiology and prevention of cervical adenocarcinomas. J Natl Cancer Inst. 2006, 98 (5): 292-293. 10.1093/jnci/djj098.CrossRefPubMed
4.
go back to reference Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM, Lai CH, Liang Y, Jung SM, Lin KH: Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer. Canc Sci. 2011, 102 (12): 2255-2263. 10.1111/j.1349-7006.2011.02102.x.CrossRef Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM, Lai CH, Liang Y, Jung SM, Lin KH: Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer. Canc Sci. 2011, 102 (12): 2255-2263. 10.1111/j.1349-7006.2011.02102.x.CrossRef
5.
go back to reference Frickel EM, Frei P, Bouvier M, Stafford WF, Helenius A, Glockshuber R, Ellgaard L: ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem. 2004, 279 (18): 18277-18287. 10.1074/jbc.M314089200.CrossRefPubMed Frickel EM, Frei P, Bouvier M, Stafford WF, Helenius A, Glockshuber R, Ellgaard L: ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem. 2004, 279 (18): 18277-18287. 10.1074/jbc.M314089200.CrossRefPubMed
6.
go back to reference Turano C, Gaucci E, Grillo C, Chichiarelli S: ERp57/GRP58: a protein with multiple functions. Cell Mol Biol Lett. 2011, 16 (4): 539-563. 10.2478/s11658-011-0022-z.CrossRefPubMed Turano C, Gaucci E, Grillo C, Chichiarelli S: ERp57/GRP58: a protein with multiple functions. Cell Mol Biol Lett. 2011, 16 (4): 539-563. 10.2478/s11658-011-0022-z.CrossRefPubMed
7.
go back to reference Hirano N, Shibasaki F, Sakai R, Tanaka T, Nishida J, Yazaki Y, Takenawa T, Hirai H: Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem. 1995, 234 (1): 336-342. 10.1111/j.1432-1033.1995.336_c.x.CrossRefPubMed Hirano N, Shibasaki F, Sakai R, Tanaka T, Nishida J, Yazaki Y, Takenawa T, Hirai H: Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem. 1995, 234 (1): 336-342. 10.1111/j.1432-1033.1995.336_c.x.CrossRefPubMed
8.
go back to reference Chichiarelli S, Gaucci E, Ferraro A, Grillo C, Altieri F, Cocchiola R, Arcangeli V, Turano C, Eufemi M: Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line. Arch Biochem Biophys. 2010, 494 (2): 178-183. 10.1016/j.abb.2009.12.004.CrossRefPubMed Chichiarelli S, Gaucci E, Ferraro A, Grillo C, Altieri F, Cocchiola R, Arcangeli V, Turano C, Eufemi M: Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line. Arch Biochem Biophys. 2010, 494 (2): 178-183. 10.1016/j.abb.2009.12.004.CrossRefPubMed
9.
go back to reference Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH: Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology. 2004, 145 (6): 2804-2814. 10.1210/en.2003-1372.CrossRefPubMed Shih CH, Chen SL, Yen CC, Huang YH, Chen CD, Lee YS, Lin KH: Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology. 2004, 145 (6): 2804-2814. 10.1210/en.2003-1372.CrossRefPubMed
10.
go back to reference Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, Chen WJ, Lin KH: Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene. 2011, 30 (17): 2057-2069. 10.1038/onc.2010.585.CrossRefPubMed Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, Chen WJ, Lin KH: Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene. 2011, 30 (17): 2057-2069. 10.1038/onc.2010.585.CrossRefPubMed
11.
go back to reference Wang CL, Wang CI, Liao PC, Chen CD, Liang Y, Chuang WY, Tsai YH, Chen HC, Chang YS, Yu JS, Wu CC, Yu CJ: Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res. 2009, 8 (10): 4428-4440. 10.1021/pr900160h.CrossRefPubMed Wang CL, Wang CI, Liao PC, Chen CD, Liang Y, Chuang WY, Tsai YH, Chen HC, Chang YS, Yu JS, Wu CC, Yu CJ: Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res. 2009, 8 (10): 4428-4440. 10.1021/pr900160h.CrossRefPubMed
12.
go back to reference Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R, Toretsky JA: Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res. 2005, 65 (14): 6199-6206. 10.1158/0008-5472.CAN-05-0455.CrossRefPubMed Uren A, Fallen S, Yuan H, Usubutun A, Kucukali T, Schlegel R, Toretsky JA: Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Res. 2005, 65 (14): 6199-6206. 10.1158/0008-5472.CAN-05-0455.CrossRefPubMed
13.
go back to reference Angers S, Moon RT: Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009, 10 (7): 468-477.CrossRefPubMed Angers S, Moon RT: Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009, 10 (7): 468-477.CrossRefPubMed
14.
go back to reference Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005, 168 (4): 633-642. 10.1083/jcb.200408051.CrossRefPubMedPubMedCentral Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005, 168 (4): 633-642. 10.1083/jcb.200408051.CrossRefPubMedPubMedCentral
15.
go back to reference Zapatka M, Zboralski D, Radacz Y, Bockmann M, Arnold C, Schoneck A, Hoppe S, Tannapfel A, Schmiegel W, Simon-Assmann P, Schwarte-Waldhoff I: Basement membrane component laminin-5 is a target of the tumor suppressor Smad4. Oncogene. 2007, 26 (10): 1417-1427. 10.1038/sj.onc.1209918.CrossRefPubMed Zapatka M, Zboralski D, Radacz Y, Bockmann M, Arnold C, Schoneck A, Hoppe S, Tannapfel A, Schmiegel W, Simon-Assmann P, Schwarte-Waldhoff I: Basement membrane component laminin-5 is a target of the tumor suppressor Smad4. Oncogene. 2007, 26 (10): 1417-1427. 10.1038/sj.onc.1209918.CrossRefPubMed
16.
go back to reference Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML: Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet. 2001, 28 (1): 53-57.PubMed Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML: Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet. 2001, 28 (1): 53-57.PubMed
17.
go back to reference Moumen M, Chiche A, Decraene C, Petit V, Gandarillas A, Deugnier MA, Glukhova MA, Faraldo MM: Myc is required for beta-catenin-mediated mammary stem cell amplification and tumorigenesis. Mol Canc. 2013, 12 (1): 132-10.1186/1476-4598-12-132.CrossRef Moumen M, Chiche A, Decraene C, Petit V, Gandarillas A, Deugnier MA, Glukhova MA, Faraldo MM: Myc is required for beta-catenin-mediated mammary stem cell amplification and tumorigenesis. Mol Canc. 2013, 12 (1): 132-10.1186/1476-4598-12-132.CrossRef
18.
go back to reference Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH: The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology. 2006, 131 (5): 1486-1500. 10.1053/j.gastro.2006.08.041.CrossRefPubMed Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH: The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Gastroenterology. 2006, 131 (5): 1486-1500. 10.1053/j.gastro.2006.08.041.CrossRefPubMed
19.
go back to reference Altieri F, Maras B, Eufemi M, Ferraro A, Turano C: Purification of a 57 kDa nuclear matrix protein associated with thiol:protein-disulfide oxidoreductase and phospholipase C activities. Biochem Biophys Res Commun. 1993, 194 (3): 992-1000. 10.1006/bbrc.1993.1919.CrossRefPubMed Altieri F, Maras B, Eufemi M, Ferraro A, Turano C: Purification of a 57 kDa nuclear matrix protein associated with thiol:protein-disulfide oxidoreductase and phospholipase C activities. Biochem Biophys Res Commun. 1993, 194 (3): 992-1000. 10.1006/bbrc.1993.1919.CrossRefPubMed
20.
go back to reference Fadare O, Reddy H, Wang J, Hileeto D, Schwartz PE, Zheng W: E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol. 2005, 3: 38-10.1186/1477-7819-3-38.CrossRefPubMedPubMedCentral Fadare O, Reddy H, Wang J, Hileeto D, Schwartz PE, Zheng W: E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol. 2005, 3: 38-10.1186/1477-7819-3-38.CrossRefPubMedPubMedCentral
21.
go back to reference Rodriguez-Sastre MA, Gonzalez-Maya L, Delgado R, Lizano M, Tsubaki G, Mohar A, Garcia-Carranca A: Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol. 2005, 97 (2): 330-336. 10.1016/j.ygyno.2004.12.062.CrossRefPubMed Rodriguez-Sastre MA, Gonzalez-Maya L, Delgado R, Lizano M, Tsubaki G, Mohar A, Garcia-Carranca A: Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol. 2005, 97 (2): 330-336. 10.1016/j.ygyno.2004.12.062.CrossRefPubMed
22.
go back to reference Harris TJ, Peifer M: Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol. 2005, 15 (5): 234-237. 10.1016/j.tcb.2005.03.002.CrossRefPubMed Harris TJ, Peifer M: Decisions, decisions: beta-catenin chooses between adhesion and transcription. Trends Cell Biol. 2005, 15 (5): 234-237. 10.1016/j.tcb.2005.03.002.CrossRefPubMed
23.
go back to reference Jaitner S, Reiche JA, Schaffauer AJ, Hiendlmeyer E, Herbst H, Brabletz T, Kirchner T, Jung A: Human telomerase reverse transcriptase (hTERT) is a target gene of beta-catenin in human colorectal tumors. Cell Cycle. 2012, 11 (17): 3331-3338. 10.4161/cc.21790.CrossRefPubMedPubMedCentral Jaitner S, Reiche JA, Schaffauer AJ, Hiendlmeyer E, Herbst H, Brabletz T, Kirchner T, Jung A: Human telomerase reverse transcriptase (hTERT) is a target gene of beta-catenin in human colorectal tumors. Cell Cycle. 2012, 11 (17): 3331-3338. 10.4161/cc.21790.CrossRefPubMedPubMedCentral
24.
go back to reference Hagen T, Sethi JK, Foxwell N, Vidal-Puig A: Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J. 2004, 379 (Pt 2): 471-477.CrossRefPubMedPubMedCentral Hagen T, Sethi JK, Foxwell N, Vidal-Puig A: Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J. 2004, 379 (Pt 2): 471-477.CrossRefPubMedPubMedCentral
25.
go back to reference Ganesan K, Ivanova T, Wu Y, Rajasegaran V, Wu J, Lee MH, Yu K, Rha SY, Chung HC, Ylstra B, Meijer G, Lian KO, Grabsch H, Tan P: Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res. 2008, 68 (11): 4277-4286. 10.1158/0008-5472.CAN-07-6517.CrossRefPubMed Ganesan K, Ivanova T, Wu Y, Rajasegaran V, Wu J, Lee MH, Yu K, Rha SY, Chung HC, Ylstra B, Meijer G, Lian KO, Grabsch H, Tan P: Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res. 2008, 68 (11): 4277-4286. 10.1158/0008-5472.CAN-07-6517.CrossRefPubMed
26.
go back to reference Shtutman M, Zhurinsky J, Oren M, Levina E, Ben-Ze'ev A: PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription. Cancer Res. 2002, 62 (20): 5947-5954.PubMed Shtutman M, Zhurinsky J, Oren M, Levina E, Ben-Ze'ev A: PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription. Cancer Res. 2002, 62 (20): 5947-5954.PubMed
27.
go back to reference Imura J, Ichikawa K, Takeda J, Fujimori T: Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma. Int J Mol Med. 2001, 8 (4): 353-358.PubMed Imura J, Ichikawa K, Takeda J, Fujimori T: Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma. Int J Mol Med. 2001, 8 (4): 353-358.PubMed
28.
go back to reference Morrice NA, Powis SJ: A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol. 1998, 8 (12): 713-716. 10.1016/S0960-9822(98)70279-9.CrossRefPubMed Morrice NA, Powis SJ: A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol. 1998, 8 (12): 713-716. 10.1016/S0960-9822(98)70279-9.CrossRefPubMed
29.
go back to reference Pedrinaci S, Algarra I, Garcia Lora A, Gaforio JJ, Perez M, Garrido F: Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. Int J Clin Lab Res. 1999, 29 (4): 166-173. 10.1007/s005990050085.CrossRefPubMed Pedrinaci S, Algarra I, Garcia Lora A, Gaforio JJ, Perez M, Garrido F: Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. Int J Clin Lab Res. 1999, 29 (4): 166-173. 10.1007/s005990050085.CrossRefPubMed
30.
go back to reference Cromme FV, van Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ: Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Canc. 1994, 69 (6): 1176-1181. 10.1038/bjc.1994.231.CrossRef Cromme FV, van Bommel PF, Walboomers JM, Gallee MP, Stern PL, Kenemans P, Helmerhorst TJ, Stukart MJ, Meijer CJ: Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Canc. 1994, 69 (6): 1176-1181. 10.1038/bjc.1994.231.CrossRef
31.
go back to reference Ouellet V, Le Page C, Guyot MC, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM: SET complex in serous epithelial ovarian cancer. Int J Cancer. 2006, 119 (9): 2119-2126. 10.1002/ijc.22054.CrossRefPubMed Ouellet V, Le Page C, Guyot MC, Lussier C, Tonin PN, Provencher DM, Mes-Masson AM: SET complex in serous epithelial ovarian cancer. Int J Cancer. 2006, 119 (9): 2119-2126. 10.1002/ijc.22054.CrossRefPubMed
32.
go back to reference Corazzari M, Lovat PE, Armstrong JL, Fimia GM, Hill DS, Birch-Machin M, Redfern CP, Piacentini M: Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer. 2007, 96 (7): 1062-1071. 10.1038/sj.bjc.6603672.CrossRefPubMedPubMedCentral Corazzari M, Lovat PE, Armstrong JL, Fimia GM, Hill DS, Birch-Machin M, Redfern CP, Piacentini M: Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer. 2007, 96 (7): 1062-1071. 10.1038/sj.bjc.6603672.CrossRefPubMedPubMedCentral
33.
go back to reference Davy ML, Dodd TJ, Luke CG, Roder DM: Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. Obstet Gynecol. 2003, 101 (1): 38-45. 10.1016/S0029-7844(02)02275-5.PubMed Davy ML, Dodd TJ, Luke CG, Roder DM: Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival. Obstet Gynecol. 2003, 101 (1): 38-45. 10.1016/S0029-7844(02)02275-5.PubMed
Metadata
Title
Glucose-regulated protein 58 modulates β-catenin protein stability in a cervical adenocarcinoma cell line
Authors
Chia-Jung Liao
Tzu-I Wu
Ya-Hui Huang
Ting-Chang Chang
Chyong-Huey Lai
Shih-Ming Jung
Chuen Hsueh
Kwang-Huei Lin
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-555

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine